Latest News & Articles
Browse all our latest news articles and stories
FAQ: Sonepar and Klein Tools' Donation to the Bob Woodruff Foundation
FAQ on AI Research for Cardiovascular Disease Screening and Treatment
FAQ: Shincheonji Church of Jesus Taekwondo Team's World Stage Achievements
The Shincheonji Church of Jesus taekwondo team excelled internationally, winning multiple medals at the 2025 Park Chung-hee Cup and Kim Un-yong Cup …
FAQ on Crypto-Linked Stocks Surge Following Stablecoins Bill Signing
Understanding White Hydrogen's Role in the Energy Transition
FAQ: The Shift Back to In-Person Dating and Gen Z's Challenges
Understanding BTCC's Reserve Ratio and Its Impact on User Asset Safety
FAQ: Amber International's Pioneering On-Chain Stock Offering
Amber International Holding Limited (NASDAQ: AMBR) has become the first Asia-based public company to offer its stock on-chain through the Solana …
FAQ on Aditxt Inc.'s Subsidiary Pearsanta's Invitation for DoD-Funded Ovarian Cancer Diagnostic Study
Aditxt Inc.'s subsidiary, Pearsanta, has been invited to submit a full proposal for a DoD-funded study on its Mitomic Ovarian Test, a novel diagnostic …
FAQ on Fusion Fuel Green PLC's $4.3 Million PIPE Financing and Capital Structure Streamlining
FAQ: Energy Fuels Inc. Q2 2025 Financial Results Conference Call
FAQ on Aston Bay Holdings Ltd.'s New Copper Intercepts at Storm Project in Nunavut
Aston Bay Holdings Ltd. reports new copper intercepts at the Storm Project in Nunavut, indicating potential for resource growth and project …
FAQ: Response24 Connect - Transforming Crisis Management for the Insurance Market
FAQ: SEGG Media Corporation's Acquisition of DotCom Ventures and Expansion into Live Entertainment
FAQ: United Franchise Group's Acquisition of Black Optix Tint®
FAQ: Mullen Automotive Inc. Rebranding to Bollinger Innovations Inc.
Mullen Automotive Inc. (NASDAQ: MULN) is rebranding to Bollinger Innovations, Inc. and will begin trading under the new ticker symbol BINI on July 28, …
FAQ on Candel Therapeutics' European Orphan Status for Pancreatic Cancer Drug CAN-2409
Understanding the Risks and Realities of Asbestos in Homes